Cluster page — primary care pharmacy
Clinical pharmacist responsibilities
Core clinical domains
The eight clinical responsibilities every primary care pharmacist covers
Structured Medication Reviews
Comprehensive person-centred review of all medications, deprescribing and shared decision-making, against the PCN DES SMR specification.
High-Risk Drug Monitoring
DMARDs, lithium, amiodarone, methotrexate, DOACs — monitoring intervals enforced per NICE/BNF, with prescribing safety alert closure.
Long-Term Condition Titration
Hypertension, lipids, type 2 diabetes, heart failure, COPD, asthma — pharmacist-led titration clinics against NICE thresholds.
Discharge Reconciliation
TCAM-compliant medicines reconciliation within 7 days of discharge, with patient phone follow-up where high-risk.
Repeat Prescribing Optimisation
Synchronisation, quantity rationalisation, expired item review, waste reduction — managed at PCN scale.
Care Home Medication Reviews
Per Enhanced Health in Care Homes DES — pharmacist sessions per home, deprescribing, end-of-life alignment.
Antimicrobial Stewardship
Audit, ICB AMS programme contribution, education, prescribing alerts, OPAT support where commissioned.
Prescribing Safety & Governance
MHRA Drug Safety Update cascade, SEA contribution, NRLS reporting, ICB prescribing safety alert closure.
Within scope — but commonly underused
Activities the role is permitted to deliver but PCNs often miss
- Pre-clinic optimisation: pharmacist reviews the GP's day-ahead caseload and pre-empts medication issues
- Post-OP and post-fracture analgesia step-down and opioid stewardship cohort review
- Frailty proactive case-finding via eFI (electronic Frailty Index) and SMR allocation
- Pharmacist-led valproate Annual Risk Acknowledgement Form (ARAF) review
- Isotretinoin and Pregnancy Prevention Programme oversight for shared care patients
- Pharmacist-led inhaler technique and asthma review clinics under PCN respiratory pathway
- Anticoagulation switch programmes (warfarin → DOAC) at PCN scale under ICB protocol
Frequently asked questions
Responsibilities — FAQs
What clinical activities are within scope for a primary care pharmacist?+
Structured Medication Reviews, high-risk drug monitoring, long-term condition titration (hypertension, lipids, diabetes, heart failure, COPD, asthma), discharge medicines reconciliation, repeat prescribing optimisation, antimicrobial stewardship, care home medication reviews, end-of-life medicines optimisation, prescribing safety alert cascade, SEA contribution and pharmacist-led query handling.
Can a primary care pharmacist diagnose?+
Pharmacists are not diagnosticians — they are not registered medical practitioners. Independent prescriber pharmacists can assess, monitor and prescribe within their documented scope of practice (typically long-term condition titration and medicines optimisation), but a new diagnosis remains the GP's responsibility.
What can a non-independent-prescriber pharmacist still do?+
All clinical review activity, SMRs, reconciliation, monitoring, audit, patient education and prescribing recommendations to the GP. The activity volume is largely unchanged; only the final prescribing signature differs. From 2026 onwards, IP qualification is the default for newly registered pharmacists.
Are care home medication reviews within scope?+
Yes, and they are explicitly within the Enhanced Health in Care Homes PCN DES service specification. Most PCNs allocate dedicated pharmacist sessions per care home, working with the GP MDT round to review medications, deprescribe, manage covert administration and align with end-of-life planning.
Talk to our Service Development team
30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.